Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy-Reference-Cited by-同舟云学术

Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy

Published:2024-06-26 Issue:13 Volume:67 Page:11086-11102
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Abyar Selda¹²,Huang Luojiao²^ORCID,Husiev Yurii¹^ORCID,Bretin Ludovic¹^ORCID,Chau Bobby¹²,Ramu Vadde¹^ORCID,Wildeman Jacob Hendricus²^ORCID,Belfor Kimberley²,Wijaya Lukas S.²,van der Noord Vera E.²,Harms Amy C.²^ORCID,Siegler Maxime A.³^ORCID,Le Dévédec Sylvia E.²,Bonnet Sylvestre¹^ORCID

Affiliation:

1. Leiden Institute of Chemistry, Leiden University, Gorlaeus Laboratories, PO Box 9502, Leiden 2300 RA, The Netherlands

2. Leiden Academic Centre for Drug Research, Leiden University, Gorlaeus Laboratories, PO Box 9502, Leiden 2300 RA, The Netherlands

3. Department of Chemistry, Johns Hopkins University, 3400 N Charles St, Baltimore, Maryland 21218, United States

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00589

Reference62 articles.

1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016

2. Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

3. Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

4. Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009

5. Should Peak Dose Be Used to Prescribe Spatially Fractionated Radiation Therapy?—A Review of Preclinical Studies